RT Journal Article
T1 Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment.
A1 García-García, Teresa
A1 Carmona-Bayonas, Alberto
A1 Jimenez-Fonseca, Paula
A1 Jara, Carlos
A1 Beato, Carmen
A1 Castelo, Beatriz
A1 Mangas, Montserrat
A1 de Castro, Eva Martínez
A1 Ramchandani, Avinash
A1 Gomez, David
A1 Calderón, Caterina
K1 Adjuvant therapy
K1 Breast cancer
K1 Healthcare
K1 Patient-centered care
K1 Psycho-oncology
AB The aim of this study was to analyze biopsychosocial factors affecting how patients cope with cancer and adjuvant treatment and to appraise psychological distress, coping, perceived social support, quality of life and SDM before and after adjuvant treatment in breast cancer patients compared to colon cancer patients. NEOcoping is a national, multicenter, cross-sectional, prospective study. The sample comprised 266 patients with colon cancer and 231 with breast cancer. The instruments used were the Brief Symptom Inventory (BSI), Mini-Mental Adjustment to Cancer (Mini-MAC), Multidimensional Scale of Perceived Social Support (MSPSS), Shared Decision-Making Questionnaire-Patient (SDM-Q-9) and Physician's (SDM-Q-Doc), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ). Breast cancer patients reacted worse to the diagnosis of cancer with more symptoms of anxiety, depression, and somatization, and were less satisfied with their involvement than those with colon cancer (p = 0.003). Participants with colon cancer were older and had more physical symptoms and functional limitations at the beginning of adjuvant treatment, while there were scarcely any differences between the two groups at the end of adjuvancy, at which time both groups suffered greater psychological and physical effects and scored lower on coping strategies, except for anxious preoccupation. Breast cancer patients need more information and involvement of the oncologist in shared decision-making, as well as and more medical and psychological support when beginning adjuvant treatment. Both breast and colon cancer patients may require additional psychological care at the end of adjuvancy.
YR 2019
FD 2019-11-26
LK http://hdl.handle.net/10668/14744
UL http://hdl.handle.net/10668/14744
LA en
DS RISalud
RD Apr 11, 2025